Why do you never respond to the arguments I put up about why the science is so important to MSB's income, through deal of the year?
(It is key to why MSB is such a different beast to the usual biotech risks).
And Macbank has no doubt got it's reasons for making an exception of MSB. I wouldn't trust their analysis for the reasons stated earlier.
As for an analyst who is son of who...how is this relevant to the stock? Or relevant to anything?
It not information that a genuine mum & dad investor would have a clue about.
Mac Bank, page-32
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.07 |
Change
0.005(0.47%) |
Mkt cap ! $1.216B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.10 | $1.06 | $3.371M | 3.135M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 45345 | $1.06 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 3875 | 2 |
View Market Depth
| Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |